Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival.

Sung H, Jeon S, Lee KM, Han S, Song M, Choi JY, Park SK, Yoo KY, Noh DY, Ahn SH, Kang D.

BMC Cancer. 2012 May 28;12:195. doi: 10.1186/1471-2407-12-195.

2.

Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.

Sung H, Lee KM, Choi JY, Han S, Lee JY, Li L, Park SK, Yoo KY, Noh DY, Ahn SH, Kang D.

Breast Cancer Res Treat. 2011 Dec;130(3):939-51. doi: 10.1007/s10549-011-1656-2. Epub 2011 Jul 16.

PMID:
21766210
3.

Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma.

Liu L, An J, Liu J, Wen J, Zhai X, Liu Y, Pan S, Jiang J, Wen Y, Liu Z, Zhang Y, Chen J, Xing J, Ji G, Shen H, Hu Z, Fan Z.

Mol Carcinog. 2013 Nov;52 Suppl 1:E148-54. doi: 10.1002/mc.22062. Epub 2013 Jul 19.

PMID:
23868705
4.

Evaluation of genetic variants in microRNA biosynthesis genes and risk of breast cancer in Chinese women.

Jiang Y, Chen J, Wu J, Hu Z, Qin Z, Liu X, Guan X, Wang Y, Han J, Jiang T, Jin G, Zhang M, Ma H, Wang S, Shen H.

Int J Cancer. 2013 Nov;133(9):2216-24. doi: 10.1002/ijc.28237. Epub 2013 Jul 11.

5.

Association of microRNA biogenesis pathway gene variants and alcohol dependence risk.

Gedik H, Erdal ME, Yilmaz SG, Sengul C, Sengul CB, Herken H.

DNA Cell Biol. 2015 Mar;34(3):220-6. doi: 10.1089/dna.2014.2549. Epub 2014 Dec 11.

PMID:
25495208
6.

Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma.

Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, Wu X.

Carcinogenesis. 2010 Oct;31(10):1805-12. doi: 10.1093/carcin/bgq168. Epub 2010 Aug 23.

7.

Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry.

Qian F, Feng Y, Zheng Y, Ogundiran TO, Ojengbede O, Zheng W, Blot W, Ambrosone CB, John EM, Bernstein L, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, Nathanson KL, Hennis A, Nemesure B, Ambs S, Kolonel LN, Olopade OI, Haiman CA, Huo D.

Hum Genet. 2016 Oct;135(10):1145-59. doi: 10.1007/s00439-016-1707-1. Epub 2016 Jul 5.

8.

Genetic variations in key microRNA processing genes and risk of head and neck cancer: a case-control study in Chinese population.

Ma H, Yuan H, Yuan Z, Yu C, Wang R, Jiang Y, Hu Z, Shen H, Chen N.

PLoS One. 2012;7(10):e47544. doi: 10.1371/journal.pone.0047544. Epub 2012 Oct 11.

9.

Complexity in regulation of microRNA machinery components in invasive breast carcinoma.

Kwon SY, Lee JH, Kim B, Park JW, Kwon TK, Kang SH, Kim S.

Pathol Oncol Res. 2014 Jul;20(3):697-705. doi: 10.1007/s12253-014-9750-5. Epub 2014 Feb 27.

PMID:
24574065
10.

Evaluation of six SNPs of MicroRNA machinery genes and risk of schizophrenia.

Zhou Y, Wang J, Lu X, Song X, Ye Y, Zhou J, Ying B, Wang L.

J Mol Neurosci. 2013 Mar;49(3):594-9. doi: 10.1007/s12031-012-9887-1. Epub 2012 Sep 27.

PMID:
23015298
11.

[Association of microRNA-related genes (DROSHA, DICER1 and GEMIN4) polymorphisms with T-cell lymphoma prognosis].

Tian X, Zhang B, Li X, Zhai K, Xu J, Chang J, Qiao Y, Zhou Y, Huang L, Chen J.

Zhonghua Xue Ye Xue Za Zhi. 2014 May;35(5):408-13. doi: 10.3760/cma.j.issn.0253-2727.2014.05.007. Chinese.

PMID:
24857210
12.

Comprehensive analysis of microRNA (miRNA) targets in breast cancer cells.

Fan M, Krutilina R, Sun J, Sethuraman A, Yang CH, Wu ZH, Yue J, Pfeffer LM.

J Biol Chem. 2013 Sep 20;288(38):27480-93. doi: 10.1074/jbc.M113.491803. Epub 2013 Aug 6.

13.

Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma.

Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J, Lin J, Habuchi T, Wu X.

Clin Cancer Res. 2008 Dec 1;14(23):7956-62. doi: 10.1158/1078-0432.CCR-08-1199.

14.

Common genetic variants in the microRNA biogenesis pathway are not associated with breast cancer risk in Asian women.

Sung H, Zhang B, Choi JY, Long J, Park SK, Yoo KY, Noh DY, Ahn SH, Zheng W, Kang D.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1385-7. doi: 10.1158/1055-9965.EPI-12-0600. Epub 2012 Jun 19.

15.

Common genetic variants in the microRNA biogenesis pathway are associated with malignant peripheral nerve sheath tumor risk in a Chinese population.

Weng Y, Chen Y, Chen J, Liu Y, Bao T.

Cancer Epidemiol. 2013 Dec;37(6):913-6. doi: 10.1016/j.canep.2013.05.003. Epub 2013 Jun 12. Retraction in: Cancer Epidemiol. 2015 Aug;39(4):664.

PMID:
23763827
16.

The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes.

Bayraktar S, Thompson PA, Yoo SY, Do KA, Sahin AA, Arun BK, Bondy ML, Brewster AM.

Oncologist. 2013;18(5):493-500. doi: 10.1634/theoncologist.2012-0419. Epub 2013 May 1.

17.

Replication study for reported SNP associations with breast cancer survival.

Beeghly-Fadiel A, Zheng W, Lu W, Long J, Zheng Y, Cai H, Gu K, Chen Z, Cai Q, Gao YT, Shu XO.

J Cancer Res Clin Oncol. 2012 Jun;138(6):1019-26. doi: 10.1007/s00432-012-1174-6. Epub 2012 Feb 25.

18.

Association of polymorphisms in microRNA machinery genes (DROSHA, DICER1, RAN, and XPO5) with risk of idiopathic primary ovarian insufficiency in Korean women.

Rah H, Jeon YJ, Lee BE, Kim JO, Shim SH, Lee WS, Choi DH, Kim JH, Kim NK.

Menopause. 2013 Oct;20(10):1067-73. doi: 10.1097/GME.0b013e3182883907.

PMID:
23549446
19.

Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.

Liang D, Meyer L, Chang DW, Lin J, Pu X, Ye Y, Gu J, Wu X, Lu K.

Cancer Res. 2010 Dec 1;70(23):9765-76. doi: 10.1158/0008-5472.CAN-10-0130. Epub 2010 Nov 30.

20.

Genetic polymorphism of miR-196a as a prognostic biomarker for early breast cancer.

Lee SJ, Seo JW, Chae YS, Kim JG, Kang BW, Kim WW, Jung JH, Park HY, Jeong JY, Park JY.

Anticancer Res. 2014 Jun;34(6):2943-9.

PMID:
24922658

Supplemental Content

Support Center